Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3967-3970, August 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Worth, L. L.
Right arrow Articles by Haddox, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worth, L. L.
Right arrow Articles by Haddox, M. K.

Phosphorylation of Ornithine Decarboxylase at Both Serine and Threonine Residues in the ODC-overproducing, Abelson Virus-transformed RAW264 Cell Line1

Laura L. Worth, Barbara J. Cochran and Mari K. Haddox2

Department of Pharmacology, The University of Texas Medical School, Houston, Texas 77225

Expression of ornithine decarboxylase (ODC), the initial enzyme in polyamine biosynthesis, is essential for cell growth. The Abelson virus-transformed, murine macrophage-derived RAW264 cell line overexpresses ODC activity and enzyme protein at a level 100–1000-fold greater than in normal cells. Expression of ODC was completely dependent on extracellular stimulants and followed a temporally discrete pattern similar to that in normal cells. ODC was present in RAW264 cells as two major and one minor isoelectric forms. Analysis of ODC isolated from [32P]orthophosphate metabolically radiolabeled cells demonstrated that the basic isoelectric enzyme form was unphosphorylated, the two more acidic forms were phosphorylated, and both phosphoserine and phosphothreonine residues were present in the phosphorylated ODC. Therefore, in the RAW264 cell line, ODC is overexpressed and phosphorylated at multiple sites on the enzyme molecule.

1 This work was supported by Grant DK44331 from the NIH.

2 To whom requests for reprints should be addressed, at Department of Pharmacology, The University of Texas Medical School, P.O. Box 20708, Houston, TX 77225.

Received 5/27/94. Accepted 6/16/94.




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
J. Shin, F. Shen, and J. R. Huguenard
Polyamines Modulate AMPA Receptor-Dependent Synaptic Responses in Immature Layer V Pyramidal Neurons
J Neurophysiol, May 1, 2005; 93(5): 2634 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Otieno and T. W. Kensler
A Role for Protein Kinase C-{{delta}} in the Regulation of Ornithine Decarboxylase Expression by Oxidative Stress
Cancer Res., August 1, 2000; 60(16): 4391 - 4396.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. G. Reddy, S. M. Mcllheran, B. J. Cochran, L. L. Worth, L. A. Bishop, P. J. Brown, V. P. Knutson, and M. K. Haddox
Multisite Phosphorylation of Ornithine Decarboxylase in Transformed Macrophages Results in Increased Intracellular Enzyme Stability and Catalytic Efficiency
J. Biol. Chem., October 4, 1996; 271(40): 24945 - 24953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.